Skip to main contentSkip to search and navigation

UEF eREPOSITORY

    • English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Combined Low-Dose Zearalenone and Aflatoxin B1 on Cell Growth and Cell-Cycle Progression in Breast Cancer MCF-7 Cells

Thumbnail
Files
Article (964.6Kb)
Self archived version
final draft
Date
2017
Author(s)
Yip Ka Yiu
Wan Murphy Lam Yim
Wong Alice Sze Tsai
Korach Kenneth S
El-Nezami Hani
Unique identifier
10.1016/j.toxlet.2017.09.022
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Yip Ka Yiu. Wan Murphy Lam Yim. Wong Alice Sze Tsai. Korach Kenneth S. El-Nezami Hani. (2017). Combined Low-Dose Zearalenone and Aflatoxin B1 on Cell Growth and Cell-Cycle Progression in Breast Cancer MCF-7 Cells.  TOXICOLOGY LETTERS, 281, 139-151. 10.1016/j.toxlet.2017.09.022.
Rights
© Elsevier B.V
Licensed under
CC BY-NC-ND https://creativecommons.org/licenses/by-nc-nd/4.0/
Abstract

Zearalenone (ZEA) has long been recognized as a xenoestrogen, while the endocrine disrupting effects of aflatoxin B1 (AFB1) have been identified recently. Due to co-occurrence and endocrine disrupting potentials of ZEA and AFB1, it was hypothesized that co-exposure to ZEA and AFB1 might affect breast cancer cell growth. Consequently, the aim of this study was to evaluate the combined effects of ZEA and AFB1 (1 nM–100 nM) on cell growth and cell cycle progression, using a human breast cancer cell line MCF-7. Our results showed that ZEA and AFB1 produced significant interactive effects on cell growth, DNA synthesis and cell cycle progression. While ZEA promoted growth, DNA synthesis and cell cycle progression, AFB1 was cytotoxic and counteracted the effects of ZEA. ZEA altered the expression of several breast cancer related genes, whereas AFB1 had minimal effects on gene expression. With the use of specific inhibitors, ERα, GPER and MAPK pathways were found to be responsible for ZEA’s effects on cell growth; while MAPK pathways might be involved in cytotoxic effects by AFB1. This study is first to report the effects of co-exposure of ZEA and AFB1 on breast cancer cell growth, possibly through ER dependent pathway. This suggested that endocrine-disrupting mycotoxins that co-occur in human food can interact and influence human health. Future work on interactive effects of endocrine-disrupting mycotoxins or other xenoestrogens is warranted, which will contribute to improved risk assessments.

Subjects
Aflatoxin B1   Breast cancer   Endocrine disruptor   Mixture   Proliferation   Zearalenone   
URI
https://erepo.uef.fi/handle/123456789/4996
Link to the original item
http://dx.doi.org/10.1016/j.toxlet.2017.09.022
Publisher
Elsevier BV
Collections
  • Terveystieteiden tiedekunta [1336]
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap
Search

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subjectThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subject

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap